During the past decade, Department of Growth and Reproduction, Rigshospitalet conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Growth and Reproduction, Rigshospitalet" #1 collaborator was "European Commission" with 1 trials as a collaborator and "The Ministry of Science, Technology and Innovation, Denmark" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Department of Growth and Reproduction, Rigshospitalet" are "Infertility, Male" (2 trials), "Analgesic Adverse Reaction" (1 trials), "Calcium Disorder" (1 trials), "Child Development" (1 trials) and "Delayed Puberty" (1 trials). Many other conditions were trialed in "Department of Growth and Reproduction, Rigshospitalet" in a lesser frequency.

Most popular intervention types in "Department of Growth and Reproduction, Rigshospitalet" are "Drug" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Denosumab" (2 trials), "Observational" (2 trials), "human chorionic gonadotropin" (2 trials), "Sodium chloride" (1 trials) and "retrospective data collection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Growth and Reproduction, Rigshospitalet" are 6 trials for "Male" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "Department of Growth and Reproduction, Rigshospitalet". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Department of Growth and Reproduction, Rigshospitalet, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Growth and Reproduction, Rigshospitalet, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".